Ambu AS (AMBU B) - Financial and Strategic SWOT Analysis Review

Ambu AS (AMBU B) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Ambu A/S (Ambu) is a medical device company that manufactures and markets life supporting devices. It focuses on single-use devices for anesthesia, endoscopy, cardiology, patient monitoring and diagnostics and emergency care. It serves hospitals, clinics, sleep laboratories and rescue services. The company's product portfolio includes ventilation products for artificial respiration, resuscitators, single-use videoscopes, electrodes for ECG tests and neurophysiological tests, and manikins for first aid training. Ambu sells its medical devices through direct sales force and a network of distributors to hospitals and ambulances worldwide and operates offices in North America, Europe and Asia-Pacific. It has production facilities in China, Malaysia, and the US. Ambu is headquartered in Ballerup, Denmark.

Ambu AS Key Recent Developments

Nov 17,2023: Ambu Notice for the Annual General Meeting
Oct 11,2023: Ambu Appoints New Chief Financial Officer
Oct 09,2023: Ambu Announces Preliminary Financial Results For The Fiscal Year 2022/23
May 03,2023: INTERIM REPORT FOR Q2 2022/23 AND THE HALF-YEAR

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note:Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Ambu A/S - Key Facts
Ambu A/S - Key Employees
Ambu A/S - Key Employee Biographies
Ambu A/S - Major Products and Services
Ambu A/S - History
Ambu A/S - Company Statement
Ambu A/S - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Ambu A/S - Business Description
Business Segment: Anaesthesia
Overview
Performance
Business Segment: Endoscopy Solutions
Overview
Performance
Business Segment: Patient Monitoring
Overview
Performance
Geographical Segment: Europe
Performance
Geographical Segment: North America
Performance
Geographical Segment: Rest of the World
Performance
R&D Overview
Ambu A/S - Corporate Strategy
Ambu A/S - SWOT Analysis
SWOT Analysis - Overview
Ambu A/S - Strengths
Ambu A/S - Weaknesses
Ambu A/S - Opportunities
Ambu A/S - Threats
Ambu A/S - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Ambu A/S, Medical Equipment, Deals By Year, 2017 to YTD 2023
Ambu A/S, Medical Equipment, Deals By Type, 2017 to YTD 2023
Ambu A/S, Recent Deals Summary
Section 5 – Company’s Recent Developments
Nov 17, 2023: Ambu Notice for the Annual General Meeting
Oct 11, 2023: Ambu Appoints New Chief Financial Officer
Oct 09, 2023: Ambu Announces Preliminary Financial Results For The Fiscal Year 2022/23
May 03, 2023: INTERIM REPORT FOR Q2 2022/23 AND THE HALF-YEAR
Feb 07, 2023: Ambu Announces Interim Report For Q1 2022/23
Nov 15, 2022: Ambu Announces Annual Report 2021/22
Oct 13, 2022: Ambu, the world leader in single-use endoscopy, hosts grand opening of new Manufacturing plant in Mexico
Aug 25, 2022: Ambu Interim Report For Q3 2021/22
Aug 03, 2022: Ambu Announces Preliminary results for Q3 2021/22, Full-year 2021/22 guidance
May 19, 2022: Britt Meelby Jensen appointed new CEO of Ambu
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Ambu A/S, Key Facts
Ambu A/S, Key Employees
Ambu A/S, Key Employee Biographies
Ambu A/S, Major Products and Services
Ambu A/S, History
Ambu A/S, Subsidiaries
Ambu A/S, Key Competitors
Ambu A/S, Ratios based on current share price
Ambu A/S, Annual Ratios
Ambu A/S, Annual Ratios (Cont...1)
Ambu A/S, Annual Ratios (Cont...2)
Ambu A/S, Interim Ratios
Ambu A/S, Medical Equipment, Deals By Year, 2017 to YTD 2023
Ambu A/S, Medical Equipment, Deals By Type, 2017 to YTD 2023
Ambu A/S, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Ambu A/S, Performance Chart (2019 - 2023)
Ambu A/S, Ratio Charts
Ambu A/S, Medical Equipment, Deals By Year, 2017 to YTD 2023
Ambu A/S, Medical Equipment, Deals by Type, 2017 to YTD 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings